Key result
The Healthy China 2030 plan outlines strategic principles including health priority, technological innovation, and balanced resource allocation to combat the rising burden of cardiovascular diseases in China.
The Healthy China 2030 plan outlines strategic principles including health priority, technological innovation, and balanced resource allocation to combat the rising morbidity and mortality of cardiovascular diseases in China.
Cardiovascular diseases (CVDs) represent the leading cause of death in China. The Chinese government approved the Healthy China 2030 plan (jiànkāng zhōngguó 2030), emphasizing the strategic role of health in China's development. As morbidity and mortality from CVDs are constantly increasing in China, the prevention and treatment of CVDs are vital to achieve this plan. Following the major principles of health priority, science and technology innovation, scientific development, and balanced medical resource allocation outlined in the Healthy China 2030 plan, this Commentary briefly introduces the current status of CVDs in China and marks the important events undertaken to achieve this plan.
No takes yet. Share an insight, caveat, or question.
Bei et al. (2018) conducted an editorial in Cardiovascular diseases. The Healthy China 2030 plan outlines strategic principles including health priority, technological innovation, and balanced resource allocation to combat the rising burden of cardiovascular diseases in China.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Cardiovascular preventionMore from BMC Medicine